Drug Trial Radar · NCT00809146
Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications
Last checked: Nov 19, 2026Latest source record: Jun 17, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,023
Actual
Start
Jun 2009
Primary completion
Jan 2011
Study completion Jan 2011
Sponsor
- Lead sponsor
- Robert SilbergleitAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medical University of South Carolina; University of California, San Francisco; National Institute of Neurological Disorders and Stroke (NINDS)
- First posted
- Dec 17, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
Conditions
- Status Epilepticus
Interventions
Intramuscular route of active treatmentDrug
IM administration by autoinjector of midazolam 5 mg for subjects under estimated weight of 40 kg or midazolam 10 mg for subjects with estimated weight of 40 kg or above, IV administration of matching volume of IV flush.
Intravenous route of active treatmentDrug
IV administration of lorazepam 2 mg for subjects under estimated weight of 40 kg or midazolam 4 mg for subjects with estimated weight of 40 kg or above, IM administration by autoinjector of matching volume of saline.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects With Termination of Seizures at ED Arrival With no Rescue Therapy GivenTime frame: Duration of prehospital care, outcome is determined upon arrival at the ED on the day of enrollment (average 20 minutes).
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
University of Arizona
Tucson, Arizona
Stanford University
Palo Alto, California
University of California-San Francisco
San Francisco, California
Emory University
Atlanta, Georgia
University of Kentucky
Lexington, Kentucky
University of Maryland
Baltimore, Maryland
Henry Ford Health System
Detroit, Michigan
Wayne State University
Detroit, Michigan
University of Minnesota
Minneapolis, Minnesota
New York Presbyterian Hospital
New York, New York
University of Cincinnati Medical Center
Cincinnati, Ohio
Oregon Health and Science University
Portland, Oregon
University of Pennsylvania/York
Philadelphia, Pennsylvania
Temple University-Main Line
Philadelphia, Pennsylvania
University of Texas-Houston
Houston, Texas
Virginia Commonwealth University
Richmond, Virginia
Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.